drugset / Trial / NCT02271295
Impact on Morbidity and Mortality of Prophylactic Dosing of Low Molecular Heparin in Child-Pugh B Cirrhotic Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
Thrombosis occurring in the small intrahepatic, as well as in the large vessels is involved in the progression of cirrhosis. Anticoagulation could reduce morbidity and mortality in cirrhotic patients
Timeline
- Start
- 2015-07-27
- Primary completion
- 2019-07-02
- Completion
- 2019-07-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Enoxaparin sodium | Other / unclassified | 4000 iu | Subcutaneous |